This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Revenue and profit rise sharply in September 2026 on leasing gains
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the quarter ended 30 September 2026, revenue rose 36% to Rs 323.58 lakh from Rs 238.18 lakh, while profit after tax rose 92% to Rs 135.06 lakh. For the half year, revenue rose 31% to Rs 564.49 lakh and profit after tax rose 64% to Rs 241.98 lakh. Leasing drove results, including a Rs 110.62 lakh gain on fixed asset sales. Operating cash flow was Rs 499.12 lakh. The limited review found no material misstatement.
Headline growth and cash flow are strong, but the Rs 110.62 lakh asset-sale gain lifts profit, so the reported rise overstates underlying growth.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹3.24 Cr | ₹2.38 Cr | +35.9% |
| Operating profit | ₹1.99 Cr | ₹0.62 Cr | +223.6% |
| Profit after tax | ₹1.35 Cr | ₹0.70 Cr | +91.7% |
| EBITDA margin | 67.9% | 34.1% | +33.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.